Global Custom Market Research Reports Provider Company

phone

Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review

  • Published Date: 05 Jul 2018
  • Number of Pages: 48
  • Category: SWOT Analysis
  • Country: United States of America
Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The companys marketed product, Hylenex is an agent for drug and fluid infusion. Its pipeline products include analog insulin PH20, for the treatment of diabetes; PEGPH20, for the treatment of pancreatic cancer; and HTI-501, for the treatment of scarring, among others. Its products are based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes affecting the extracellular matrix. Its Enhanze technology is a novel drug delivery platform proposed to enhance the absorption and dispersion of biologics. The company has partnerships with Pfizer, Roche, Baxter and Intrexon for the development and commercialization of drugs. Halozyme is headquartered in San Diego, California, the US.

Halozyme Therapeutics Inc Key Recent Developments

May 10,2018: Halozyme Reports First Quarter 2018 Results
Feb 20,2018: Halozyme Reports Fourth Quarter And Full-Year 2017 Results
Jan 09,2018: Halozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018
Nov 07,2017: Halozyme Reports Third Quarter 2017 Results
Sep 14,2017: Halozyme Increases 2017 Financial Guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Halozyme Therapeutics Inc - Key Facts 6
Halozyme Therapeutics Inc - Key Employees 7
Halozyme Therapeutics Inc - Key Employee Biographies 8
Halozyme Therapeutics Inc - Major Products and Services 9
Halozyme Therapeutics Inc - History 10
Halozyme Therapeutics Inc - Company Statement 13
Halozyme Therapeutics Inc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 Company Analysis 16
Company Overview 16
Halozyme Therapeutics Inc - Business Description 17
Geographical Segment: All other foreign 17
Performance 17
Geographical Segment: Switzerland 17
Performance 17
Geographical Segment: The US 17
Performance 17
R&D Overview 18
Halozyme Therapeutics Inc - Corporate Strategy 19
Halozyme Therapeutics Inc - SWOT Analysis 20
SWOT Analysis - Overview 20
Halozyme Therapeutics Inc - Strengths 20
Halozyme Therapeutics Inc - Weaknesses 21
Halozyme Therapeutics Inc - Opportunities 22
Halozyme Therapeutics Inc - Threats 23
Halozyme Therapeutics Inc - Key Competitors 24
Section 3 Company Financial Ratios 25
Financial Ratios - Capital Market Ratios 25
Financial Ratios - Annual Ratios 26
Performance Chart 28
Financial Performance 28
Financial Ratios - Interim Ratios 29
Financial Ratios - Ratio Charts 30
Section 4 Companys Lifesciences Financial Deals and Alliances 31
Halozyme Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Halozyme Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Halozyme Therapeutics Inc, Recent Deals Summary 33
Section 5 Companys Recent Developments 34
May 10, 2018: Halozyme Reports First Quarter 2018 Results 34
Feb 20, 2018: Halozyme Reports Fourth Quarter And Full-Year 2017 Results 35
Jan 09, 2018: Halozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018 36
Nov 07, 2017: Halozyme Reports Third Quarter 2017 Results 37
Sep 14, 2017: Halozyme Increases 2017 Financial Guidance 39
Aug 08, 2017: Halozyme Reports Second Quarter 2017 Results 40
May 09, 2017: Halozyme Reports First Quarter 2017 Financial Results 41
Feb 28, 2017: Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results 42
Section 6 Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48

List Of Tables

List of Tables
Halozyme Therapeutics Inc, Key Facts 6
Halozyme Therapeutics Inc, Key Employees 7
Halozyme Therapeutics Inc, Key Employee Biographies 8
Halozyme Therapeutics Inc, Major Products and Services 9
Halozyme Therapeutics Inc, History 10
Halozyme Therapeutics Inc, Subsidiaries 15
Halozyme Therapeutics Inc, Key Competitors 24
Halozyme Therapeutics Inc, Ratios based on current share price 25
Halozyme Therapeutics Inc, Annual Ratios 26
Halozyme Therapeutics Inc, Annual Ratios (Cont...1) 27
Halozyme Therapeutics Inc, Interim Ratios 29
Halozyme Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Halozyme Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Halozyme Therapeutics Inc, Recent Deals Summary 33
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47

List Of Figures

List of Figures
Halozyme Therapeutics Inc, Performance Chart (2013 - 2017) 28
Halozyme Therapeutics Inc, Ratio Charts 30
Halozyme Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Halozyme Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

TOP Ships Inc (TOPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Payton Planar Magnetics Ltd (PAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

View Report

Allied Motion Technologies, Inc. (AMOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports